Insurance · Founded 2007 · www.canarahsbclife.com · BSE 544583 · NSE CANHLIFE · ISIN INE01TY01017
No Notes Added Yet
Business
Canara HSBC Life Insurance Company Ltd. is an Indian life insurance provider. Its core business involves offering a range of life insurance products to individuals and groups, encompassing protection, savings, and investment-linked solutions. The company's business model relies on generating premium income from policyholders for various products like term plans, endowment plans, unit-linked insurance plans (ULIPs), and retirement solutions. It makes money through premium collection, investment income earned on policyholder funds, and fees/charges levied on certain products, while managing mortality, morbidity, and longevity risks. A significant portion of its business is derived through the bankassurance channel, leveraging its promoter banks' extensive networks.
Revenue Mix
While specific breakdowns are not publicly detailed for every segment, the revenue mix is primarily composed of:
Individual Business: Sale of policies to individual customers, covering protection (term plans), savings (traditional endowment, money-back), and investment-linked (ULIPs) products.
Group Business: Offering group term life, group credit life, and other employee benefit schemes to corporate entities and associations.
Product Mix: Revenue is generated from both traditional participating and non-participating products, and market-linked unit-linked insurance plans (ULIPs).
Distribution Channels: A major contributor to revenue is the bankassurance channel, leveraging the vast customer base and branch network of Canara Bank and other partners. Other channels include agency, direct sales, and digital platforms.
Industry
The Indian life insurance industry is highly competitive, comprising a large public sector player (LIC) and numerous private sector companies. The market is characterized by low penetration but high growth potential, driven by a large insurable population and increasing financial awareness. Canara HSBC Life Insurance is positioned as a mid-to-large private sector life insurer. Its key positioning advantage stems from its joint venture structure, providing it with direct access to the large customer bases and extensive branch networks of its promoter banks (Canara Bank and HSBC), which underpins a strong bankassurance distribution model.
MOAT
Brand Trust & Parentage: Leverages the strong brand recognition and trust associated with its promoter banks, Canara Bank (a large public sector bank) and HSBC (a global financial services giant), which is crucial in the trust-sensitive insurance sector.
Distribution Network: Significant advantage through the deep and wide branch networks of its promoter banks, providing unparalleled access to customers across India, particularly for the bankassurance model.
Regulatory Barriers: The life insurance industry has high entry barriers due to significant capital requirements, stringent regulatory compliance, and the need for long-term customer commitments, which protects existing players.
Product Expertise: Ability to develop and distribute diverse products, drawing on the financial expertise of its global and domestic banking partners.
Growth Drivers
Underpenetration of Insurance: India's low insurance penetration compared to global averages presents a substantial long-term growth opportunity.
Rising Disposable Income & Savings: A growing middle class and increasing financial awareness lead to higher demand for protection and long-term savings products.
Favorable Demographics: A large, young, working population offers a vast potential customer base.
Digitalization: Adoption of digital channels for sales, service, and policy management can enhance reach and efficiency, especially in tier 2/3 cities.
Enhanced Awareness: Increased awareness for health and protection post-pandemic can drive demand for pure protection plans.
Expanded Bankassurance Reach: Continued expansion of promoter banks' branch networks and deepened engagement can boost policy sales.
Risks
Interest Rate Fluctuations: Changes in interest rates can impact investment returns, affecting profitability and product pricing, especially for traditional guaranteed products.
Regulatory Changes: The Indian insurance regulator (IRDAI) frequently introduces new guidelines on product design, distribution, capital requirements, and commissions, which can affect business models and profitability.
Intense Competition: The presence of numerous public and private players leads to aggressive pricing and high customer acquisition costs.
Market Volatility: Investment-linked products (ULIPs) and the performance of the investment portfolio are susceptible to capital market fluctuations.
Mortality/Morbidity Experience: Higher-than-expected claims due to adverse mortality or morbidity experience could impact underwriting profits.
Distribution Dependency: High reliance on the bankassurance channel means performance can be significantly affected by the priorities and strategic focus of the promoter banks.
Management & Ownership
Canara HSBC Life Insurance Company Ltd. is a joint venture between Canara Bank, a prominent Indian public sector bank, and HSBC Insurance (Asia Pacific) Holdings Limited, a subsidiary of the global banking and financial services organization HSBC Group. Oriental Bank of Commerce (which later merged with Punjab National Bank) was also a founding partner. The company is managed by a professional board and executive team, drawing expertise and corporate governance standards from its parent entities. Ownership is split among these promoters, with Canara Bank and HSBC being the major shareholders.
Outlook
Canara HSBC Life Insurance is well-positioned to capitalize on India's long-term insurance growth story, driven by its robust bankassurance channel, the trusted brands of its promoters, and the increasing financial literacy in the country. The company's ability to leverage the vast customer bases of Canara Bank and HSBC provides a distinct advantage in distribution and customer acquisition. However, the outlook is balanced by significant challenges including intense competition from both public and private insurers, potential regulatory shifts that could impact product structures or capital requirements, and the need to continuously innovate to meet evolving customer needs and digital expectations. Sustained success will depend on effective risk management, diversification of product offerings, and strategic expansion beyond its core bankassurance channel while maintaining strong customer service and operational efficiency.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Net Sales | 1829 | 2005 | 2703 | 2260 | 2867 | 3061 |
| Other Income | 1531 | -438 | 80 | 118 | 1436 | -1764 |
| Total Income | 3360 | 1567 | 2784 | 2377 | 4303 | 1297 |
| Total Expenditure | 3317 | 1539 | 2749 | 2332 | 4272 | 1258 |
| Operating Profit | 43 | 28 | 35 | 45 | 31 | 39 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 43 | 28 | 35 | 45 | 31 | 39 |
| Provision for Tax | 6 | -1 | 3 | 4 | 3 | 4 |
| Profit After Tax | 37 | 29 | 32 | 41 | 28 | 35 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 37 | 29 | 32 | 41 | 28 | 35 |
| Adjusted Earnings Per Share | 0.4 | 0.3 | 0.3 | 0.4 | 0.3 | 0.4 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1642 | 2045 | 2280 | 2752 | 3450 | 3889 | 5026 | 5824 | 7030 | 6933 | 7850 | 10891 |
| Other Income | 1868 | -14 | 1519 | 1006 | 1071 | -811 | 4295 | 2836 | 1468 | 4929 | 2776 | -130 |
| Total Income | 3510 | 2032 | 3799 | 3759 | 4522 | 3078 | 9321 | 8660 | 8498 | 11862 | 10626 | 10761 |
| Total Expenditure | 3422 | 1901 | 3721 | 3636 | 4248 | 2867 | 8847 | 8407 | 8339 | 11680 | 10545 | 10611 |
| Operating Profit | 88 | 131 | 77 | 123 | 274 | 211 | 474 | 253 | 158 | 182 | 81 | 150 |
| Interest | 3 | 3 | 4 | 4 | 5 | 6 | 6 | 7 | 8 | 9 | 8 | 0 |
| Depreciation | 7 | 8 | 7 | 6 | 7 | 8 | 13 | 17 | 19 | 23 | 22 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 103 | 126 | 111 | 168 | 165 | 105 | 102 | 10 | 100 | 124 | 128 | 150 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 9 | 11 | 11 | 14 |
| Profit After Tax | 103 | 126 | 111 | 168 | 165 | 105 | 95 | 10 | 91 | 113 | 117 | 136 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 103 | 126 | 111 | 168 | 165 | 105 | 95 | 10 | 91 | 113 | 117 | 136 |
| Adjusted Earnings Per Share | 1.1 | 1.3 | 1.2 | 1.8 | 1.7 | 1.1 | 1 | 0.1 | 1 | 1.2 | 1.2 | 1.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 13% | 10% | 15% | 17% |
| Operating Profit CAGR | -55% | -32% | -17% | -1% |
| PAT CAGR | 4% | 127% | 2% | 1% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 8% | 8% | 6% | 13% |
| ROCE Average | 9% | 8% | 7% | 13% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 510 | 636 | 747 | 915 | 1080 | 1186 | 1280 | 1290 | 1353 | 1419 | 1517 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 9231 | 9053 | 10582 | 11901 | 14018 | 14368 | 20552 | 25276 | 29213 | 36423 | 40367 |
| Total Current Liabilities | 203 | 236 | 251 | 319 | 375 | 392 | 754 | 649 | 744 | 909 | 1030 |
| Total Liabilities | 9944 | 9925 | 11581 | 13135 | 15473 | 15946 | 22586 | 27215 | 31310 | 38751 | 42914 |
| Fixed Assets | 14 | 10 | 8 | 8 | 10 | 32 | 37 | 42 | 48 | 54 | 42 |
| Other Non-Current Assets | 9784 | 9786 | 11284 | 12689 | 14859 | 15379 | 21882 | 26306 | 30231 | 37432 | 41271 |
| Total Current Assets | 146 | 129 | 289 | 439 | 605 | 535 | 667 | 867 | 1031 | 1265 | 1601 |
| Total Assets | 9944 | 9925 | 11581 | 13135 | 15473 | 15946 | 22586 | 27215 | 31310 | 38751 | 42914 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 49 | 14 | -7 | 122 | 211 | 268 | 168 | 272 | 1191 | 1179 | 1397 |
| Cash Flow from Operating Activities | -414 | -40 | 92 | 463 | 1199 | 1338 | 2340 | 1998 | 2592 | 2310 | 1208 |
| Cash Flow from Investing Activities | 379 | 19 | 36 | -375 | -1142 | -1438 | -2236 | -1929 | -2576 | -2045 | -714 |
| Cash Flow from Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -29 | -48 | -19 |
| Net Cash Inflow / Outflow | -35 | -21 | 128 | 89 | 58 | -100 | 103 | 69 | -12 | 218 | 474 |
| Closing Cash & Cash Equivalent | 14 | -7 | 122 | 211 | 268 | 168 | 272 | 340 | 1179 | 1397 | 1872 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.08 | 1.33 | 1.17 | 1.77 | 1.74 | 1.11 | 1 | 0.11 | 0.96 | 1.19 | 1.23 |
| CEPS(Rs) | 1.08 | 1.33 | 1.17 | 1.77 | 1.74 | 1.11 | 1 | 0.11 | 0.96 | 1.19 | 1.23 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.3 | 0.2 | 0.4 |
| Book NAV/Share(Rs) | 5.37 | 6.7 | 7.87 | 9.63 | 11.37 | 12.48 | 13.48 | 13.58 | 14.24 | 14.94 | 15.97 |
| Core EBITDA Margin(%) | -108.34 | 7.05 | -63.22 | -32.1 | -23.11 | 26.28 | -76 | -44.35 | -18.63 | -68.48 | -34.33 |
| EBIT Margin(%) | 6.27 | 6.16 | 4.88 | 6.1 | 4.79 | 2.7 | 2.03 | 0.18 | 1.42 | 1.79 | 1.63 |
| Pre Tax Margin(%) | 6.27 | 6.16 | 4.88 | 6.1 | 4.79 | 2.7 | 2.03 | 0.18 | 1.42 | 1.79 | 1.63 |
| PAT Margin (%) | 6.27 | 6.16 | 4.88 | 6.1 | 4.79 | 2.7 | 1.88 | 0.18 | 1.3 | 1.63 | 1.49 |
| Cash Profit Margin (%) | 6.27 | 6.16 | 4.88 | 6.1 | 4.79 | 2.7 | 1.88 | 0.18 | 1.3 | 1.63 | 1.49 |
| ROA(%) | 1.14 | 1.3 | 1.06 | 1.39 | 1.18 | 0.69 | 0.51 | 0.04 | 0.32 | 0.33 | 0.29 |
| ROE(%) | 22.43 | 21.99 | 16.08 | 20.19 | 16.56 | 9.28 | 7.68 | 0.8 | 6.9 | 8.18 | 7.97 |
| ROCE(%) | 22.43 | 21.99 | 16.08 | 20.19 | 16.56 | 9.28 | 8.28 | 0.8 | 7.55 | 8.94 | 8.73 |
| Receivable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.57 | 0.47 | 0.36 | 0.27 | 0.2 | 0.2 | 0.14 | 0.1 | 0.08 | 0.08 | 0.04 |
| EV/Core EBITDA(x) | 10.6 | 7.32 | 10.69 | 6.02 | 2.49 | 3.7 | 1.43 | 2.41 | 3.56 | 2.9 | 4.18 |
| Net Sales Growth(%) | -9.24 | 24.54 | 11.48 | 20.72 | 25.36 | 12.71 | 29.25 | 15.87 | 20.7 | -1.38 | 13.24 |
| EBIT Growth(%) | 55.45 | 22.45 | -11.7 | 50.85 | -1.58 | -36.39 | -2.82 | -89.97 | 874.39 | 24.09 | 3.45 |
| PAT Growth(%) | 55.45 | 22.45 | -11.7 | 50.85 | -1.58 | -36.39 | -9.96 | -89.17 | 790.27 | 24.26 | 3.23 |
| EPS Growth(%) | 55.45 | 22.45 | -11.7 | 50.85 | -1.58 | -36.39 | -9.96 | -89.17 | 790.27 | 24.26 | 3.23 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 0.7 | 0.54 | 1.14 | 1.35 | 1.58 | 1.32 | 0.86 | 1.3 | 1.35 | 1.35 | 1.51 |
| Quick Ratio(x) | 0.7 | 0.54 | 1.14 | 1.35 | 1.58 | 1.32 | 0.86 | 1.3 | 1.35 | 1.35 | 1.51 |
| Interest Cover(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Oct 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 62 | 62 | 62 |
| FII | 6.97 | 4.57 | 5.68 |
| DII | 26.22 | 30.85 | 29.79 |
| Public | 4.8 | 2.58 | 2.54 |
| Others | 0 | 0 | 0 |
| Total | 100 | 100 | 100 |
| # | Oct 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 58.9 | 58.9 | 58.9 |
| FII | 6.62 | 4.34 | 5.39 |
| DII | 24.91 | 29.31 | 28.3 |
| Public | 4.56 | 2.45 | 2.41 |
| Others | 0 | 0 | 0 |
| Total | 95 | 95 | 95 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +13% | +10% | +15% | +17% |
| Operating Profit CAGR | -55% | -32% | -17% | -1% |
| PAT CAGR | +4% | +127% | +2% | +1% |
| Share Price CAGR | — | — | — | — |
| ROE Average | +8% | +8% | +6% | +13% |
| ROCE Average | +9% | +8% | +7% | +13% |
| # | Oct 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 62 | 62 | 62 |
| FII | 6.97 | 4.57 | 5.68 |
| DII | 26.22 | 30.85 | 29.79 |
| Public | 38 | 38 | 38 |
| Others | 0 | 0 | 0 |
| Total | 100 | 100 | 100 |
| # | Oct 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 58.9 | 58.9 | 58.9 |
| FII | 6.62 | 4.34 | 5.39 |
| DII | 24.91 | 29.31 | 28.3 |
| Public | 36.1 | 36.1 | 36.1 |
| Others | 0 | 0 | 0 |
| Total | 95 | 95 | 95 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.